Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.45 |
| ▸ | MCL1 | Q07820 | 11/20 | 0.41 |
| ▸ | BCL2L1 | Q07817 | 5/20 | 0.41 |
| ▸ | BCL2 | P10415 | 8/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.38 |
| ▸ | FNTA | P49354 | 2/20 | 0.38 |
| ▸ | PKM | P14618 | 1/20 | 0.38 |
| ▸ | PGGT1B | P53609 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | FNTB | P49356 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL754684 | 0.78 | MEN1 (0.40) | MEN1KMT2AMCL1BCL2L1BCL2 | |
| SCHEMBL20377643 | 0.78 | MEN1 (0.40) | MEN1KMT2AMCL1BCL2L1BCL2 | |
| SCHEMBL3971638 | 0.77 | MEN1 (0.45) | MEN1KMT2AMCL1BCL2L1BCL2 | |
| SCHEMBL28455197 | 0.76 | MEN1 (0.38) | MEN1KMT2AMCL1BCL2L1BCL2 | |
| SCHEMBL15914353 | 0.69 | FNTA (0.46) | MEN1KMT2AFNTAMAPTFNTB | |
| SCHEMBL21048486 | 0.69 | FNTA (0.46) | MEN1KMT2AFNTAMAPTFNTB | |
| SCHEMBL15914355 | 0.69 | FNTA (0.46) | MEN1KMT2AFNTAMAPTFNTB | |
| SCHEMBL15914964 | 0.69 | FNTA (0.46) | MEN1KMT2AFNTAMAPTFNTB | |
| SCHEMBL15914963 | 0.69 | FNTA (0.46) | MEN1KMT2AFNTAMAPTFNTB | |
| SCHEMBL28107053 | 0.68 | KMT2A (0.45) | MEN1KMT2AMCL1BCL2L1BCL2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117920341-A | Modified hydrolytic filler, preparation method and application thereof, and preparation method of formaldehyde-formic acid aqueous solution | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | claimed |
| EP-4532614-A1 | WATERBORNE ANTIFOULING COMPOSITION | Jotun A/S (NO) | 2025-04-09 | — | — | EP | disclosed |
| WO-2025051850-A1 | ANTIFOULING COATING SYSTEM | JOTUN A/S (NO) | 2025-03-13 | — | — | WO | disclosed |
| WO-2024202340-A1 | METHOD FOR SELECTIVELY MODIFYING SUBSTRATE SURFACE, METHOD FOR PRODUCING SURFACE-TREATED SUBSTRATE, AND COMPOSITION | JSR株式会社 | 2024-10-03 | — | — | WO | disclosed |
| CN-117920341-A | Modified hydrolytic filler, preparation method and application thereof, and preparation method of formaldehyde-formic acid aqueous solution | 中国石油化工股份有限公司 | 2024-04-26 | — | — | CN | disclosed |
| WO-2023232825-A1 | WATERBORNE ANTIFOULING COMPOSITION | JOTUN A/S (NO) | 2023-12-07 | — | — | WO | disclosed |
| CN-111601856-B | Stain-proofing composition | 佐敦有限公司 | 2023-05-23 | — | — | CN | disclosed |
| CN-110835486-B | Antifouling composition | 佐敦有限公司 | 2022-11-29 | — | — | CN | disclosed |
| CN-109777298-B | Antifouling coating composition | 佐敦有限公司 | 2022-07-12 | — | — | CN | disclosed |
| CN-109777178-B | Antifouling composition | 佐敦有限公司 | 2022-02-01 | — | — | CN | disclosed |
| CN-110835486-A | Antifouling composition | 佐敦有限公司 | 2020-02-25 | — | — | CN | disclosed |
| WO-2019179917-A1 | COMPOSITION | JOTUN A/S (NO) | 2019-09-26 | — | — | WO | disclosed |
| WO-2018158437-A1 | COMPOSITION | JOTUN A/S (NO) | 2018-09-07 | — | — | WO | disclosed |
| WO-2018158436-A1 | COMPOSITION | JOTUN A/S (NO) | 2018-09-07 | — | — | WO | disclosed |
| EP-1695956-B1 | CYCLIC CARBOXYLIC ACID COMPOUND AND USE THEREOF | CHUGOKU MARINE PAINTS (JP) | 2012-06-20 | — | — | EP | disclosed |
| US-7557148-B2 | Cyclic carboxylic acid compound and use thereof | CHUGOKU MARINE PAINTS, LTD. (JP) | 2009-07-07 | — | — | US | disclosed |
| US-7557148-B2 | Cyclic carboxylic acid compound and use thereof | CHUGOKU MARINE PAINTS, LTD. (JP) | 2009-07-07 | — | — | US | disclosed |
| US-20070105976-A1 | Cyclic carboxylic acid compound and use thereof | CHUGOKU MARINE PLANTS, LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| US-20070105976-A1 | Cyclic carboxylic acid compound and use thereof | CHUGOKU MARINE PLANTS, LTD. (JP) | 2007-05-10 | — | — | US | disclosed |
| EP-1695956-A1 | CYCLIC CARBOXYLIC ACID COMPOUND AND USE THEREOF | CHUGOKU MARINE PAINTS, LTD. (JP) | 2006-08-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070105976-A1 | Cyclic carboxylic acid compound and use thereof | PORCN, PHOSPHO1, CA1 | MEN1 3804/4885KMT2A 1269/4885MCL1 4130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.